Medical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005
2007; Wiley; Volume: 46; Issue: 8 Linguagem: Inglês
10.1111/j.1365-4632.2007.03316.x
ISSN1365-4632
AutoresJemima E. Mellerio, Madeline Weiner, Jacqueline Denyer, Elizabeth Pillay, Anne W. Lucky, Anna L. Bruckner, Francis Palisson,
Tópico(s)Connective tissue disorders research
ResumoInternational Journal of DermatologyVolume 46, Issue 8 p. 795-800 Medical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005 Jemima E. Mellerio BSc, MD, MRCP, Jemima E. Mellerio BSc, MD, MRCP From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorMadeline Weiner RN, BSN, Madeline Weiner RN, BSN From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorJacqueline E. Denyer RGN, RSCN, RHV, Jacqueline E. Denyer RGN, RSCN, RHV From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorElizabeth I. Pillay RGN, RM, RHV, Elizabeth I. Pillay RGN, RM, RHV From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorAnne W. Lucky MD, Anne W. Lucky MD From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorAnna Bruckner MD, Anna Bruckner MD From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorFrancis Palisson MD, Francis Palisson MD From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this author Jemima E. Mellerio BSc, MD, MRCP, Jemima E. Mellerio BSc, MD, MRCP From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorMadeline Weiner RN, BSN, Madeline Weiner RN, BSN From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorJacqueline E. Denyer RGN, RSCN, RHV, Jacqueline E. Denyer RGN, RSCN, RHV From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorElizabeth I. Pillay RGN, RM, RHV, Elizabeth I. Pillay RGN, RM, RHV From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorAnne W. Lucky MD, Anne W. Lucky MD From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorAnna Bruckner MD, Anna Bruckner MD From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this authorFrancis Palisson MD, Francis Palisson MD From the St John's Institute of Dermatology, St Thomas' Hospital, London, UK, Department of Dermatology, Great Ormond Street Hospital for Children, London, UK, Dystrophic Epidermolysis Bullosa Research Association (DebRA) of America (New York, NY, USA), DebRA UK, Crowthorne, Berkshire, UK, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, Stanford University School of Medicine, Stanford, California, and Facultad de Medicina Clínica Alemana, Universidad del Desarrollo and DebRA Chile Foundation, Santiago, ChileSearch for more papers by this author First published: 21 July 2007 https://doi.org/10.1111/j.1365-4632.2007.03316.xCitations: 48 Jemima E. Mellerio, BSc, MD, MRCP St John's Institute of Dermatology St Thomas' Hospital London SE1 7EH, UK E-mail: jemima.mellerio@kcl.ac.uk Drug names amitriptyline: Triptafen (Goldshield) 0.025% beclomethasone dipropionate ointment: Propaderm ointment (GlaxoSmithKline) 0.15% benzydamine hydrochloride: Difflam (3M) domperidone: Motilium (Sanofi-Synthelabo) fentanyl lozenges: Actiq (Cephalon) gabapentin: Neurotonin (Parke-Davis) 1% hydrogen peroxide cream: Crystacide (GP Pharma, UK) iron sucrose: Venofer (Syner-Medical) midazolam: Hypnovel (Roche) polyethylene glycol: Miralax (Braintree Laboratories, Inc.) ranitidine: Zantac (GlaxoSmithKline) Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume46, Issue8August 2007Pages 795-800 RelatedInformation
Referência(s)